Outpatient-Based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Background. Intravenous alemtuzumab and fludarabine are effective in combination for the treatment of chronic lymphocytic leukemia (CLL), but require hospital visits for intravenous injection. We performed a pilot study to assess the safety and efficacy of outpatient-based oral fludarabine with subc...

Descripció completa

Dades bibliogràfiques

Autors principals:	William Y. K. Hwang, Claire Dearden, Yvonne S. M. Loh, Yeh C. Linn, Sim L. Tien, Gerrard K. H. Teoh, Gee F. How, Kee K. Heng, Yeow T. Goh, Lai H. Lee
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2009-01-01
Col·lecció:	Advances in Hematology
Accés en línia:	http://dx.doi.org/10.1155/2009/547582
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!